Application of proprotein convertase subtilisin/kexin type 9 inhibitor, evolocumab, in patients with severe hypertriglyceridemia

相关推荐

• The difference of immunologic parameters between SARS patients of mild type and severe type
• Application of damage control orthopedics in 41 patients with severe multiple injuries
• Application of trauma time axis management in the treatment of severe trauma patients
• Application of ulinastatin in severe craniocerebral injuries
• First aid strategy for severe traumatic patients in hospital

同分类资源 更多

• [医药卫生] 硫酸镁联合拉贝洛尔对早发重度子痫前期患者的疗效及对血清sFlt-1、PLGF浓度和sFlt-1/PLGF比值的影响
• [医药卫生] 伊伐布雷定治疗老年心力衰竭的效果及安全性评价
• [医药卫生] 左旋甲状腺素对妊娠期甲状腺功能减退症患者妊娠并发症和妊娠结局的影响
• [医药卫生] 瑞舒伐他汀治疗冠心病的效果及对患者血清IL-17、TGF-β1、sCD40L水平的影响
• [医药卫生] 盐酸利托君与硫酸镁注射液治疗高龄孕妇先兆早产的效果对比

相关关键词